# OnCo record trk-950 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/trk-950/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "trk-950" ;
  schema:name "TRK-950"@en ;
  schema:description "TRK-950 is an experimental investigational agent whose form is not stated in the registry from Toray Industries in phase 2 trials for gastric & gastro-oesophageal junction cancer and melanoma, aimed at NTRK."@en ;
  schema:url <https://onco.cc/drugs/trk-950/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=TRK-950>, <https://www.toray.com> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "monoclonal antibody (per the sponsor's pipeline page; form not stated in the registry record)" ;
  onco:cancers <https://onco.cc/cancers/gastric/>, <https://onco.cc/cancers/melanoma/> ;
  onco:targets <https://onco.cc/targets/ntrk/> ;
  onco:companies <https://onco.cc/companies/toray-industries/> ;
  onco:trials <https://onco.cc/trials/nct05423262/>, <https://onco.cc/trials/nct06038578/> .